Search Results - "Morio, Reona"
-
1
The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy
Published in PloS one (10-08-2017)“…The risk of hepatocellular carcinoma (HCC) development is reduced following viral elimination by interferon therapy in chronic hepatitis C patients. However,…”
Get full text
Journal Article -
2
Comparison of hepatic arterial infusion chemotherapy between 5‐fluorouracil‐based continuous infusion chemotherapy and low‐dose cisplatin monotherapy for advanced hepatocellular carcinoma
Published in Hepatology research (01-12-2018)“…Aim The aim of this study is to compare the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) between 5‐fluorouracil (5‐FU)‐based continuous…”
Get full text
Journal Article -
3
Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma
Published in Journal of computer assisted tomography (01-07-2016)“…This study aimed to assess the value of preoperative fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography (F-FDG PET-CT) for…”
Get full text
Journal Article -
4
Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis
Published in Hepatology communications (01-03-2019)“…Although the effect of levocarnitine (L‐carnitine) on hyperammonemia has been reported in patients with liver cirrhosis (LC), its effect on sarcopenia remains…”
Get full text
Journal Article -
5
Advanced liver fibrosis effects on the response to sofosbuvir‐based antiviral therapies for chronic hepatitis C
Published in Journal of medical virology (01-12-2018)“…Background Sustained virological response (SVR) rates for the treatment of chronic hepatitis C virus (HCV)–infected patients have drastically improved with the…”
Get full text
Journal Article -
6
The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease
Published in Journal of gastroenterology (01-02-2017)“…Background Nonalcoholic fatty liver disease (NAFLD) is frequently associated with insulin resistance (IR) and abnormalities in glucose metabolism. Prevalent…”
Get full text
Journal Article -
7
Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C
Published in Journal of gastroenterology (01-04-2017)“…Background Daclatasvir and asunaprevir combination therapy has shown a high virological response for chronic genotype 1 hepatitis C virus (HCV)-infected…”
Get full text
Journal Article -
8
Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients
Published in Journal of gastroenterology and hepatology (01-03-2017)“…Daclatasvir and asunaprevir combination therapy has shown a high virological response for chronic genotype 1 hepatitis C virus (HCV) infected-patients…”
Get full text
Journal Article -
9
Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma
Published in Hepatology research (01-02-2018)“…Aim To evaluate the safety and efficacy of stereotactic body radiotherapy (SBRT) for the treatment of hepatocellular carcinoma (HCC) in elderly patients…”
Get full text
Journal Article -
10
Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma
Published in European radiology (01-11-2015)“…Objective Non-simple nodules in hepatocellular carcinoma (HCC) correlate with poor prognosis. Therefore, we examined the diagnostic ability of…”
Get full text
Journal Article -
11
Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection
Published in Hepatology research (01-07-2017)“…Aim FibroScan is a tool for the non‐invasive diagnosis of hepatic fibrosis. Previous studies have compared liver stiffness to percutaneous liver biopsy…”
Get full text
Journal Article -
12
Improvement of renal dysfunction in a patient with hepatitis C virus‐related liver cirrhosis by daclatasvir and asunaprevir combination therapy: A case report
Published in Hepatology research (01-08-2016)“…Recently, treatments for chronic hepatitis C virus (HCV) infection have been drastically improved by the development of direct‐acting antiviral agents. In…”
Get full text
Journal Article -
13
Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C
Published in Hepatology research (01-11-2016)“…Aim Polymorphisms in the ITPA gene influence anemia during peg‐interferon (PEG‐IFN) and ribavirin (RBV) therapy, but their effects during triple therapy with…”
Get full text
Journal Article -
14
A case of chronic hepatitis C with pancreas divisum and acute pancreatitis during combination treatment with telaprevir/peginterferon/ribavirin
Published in Nippon Shōkakibyō Gakkai zasshi (01-10-2014)“…A 47-year-old man developed acute pancreatitis during combination treatment with telaprevir/peginterferon/ribavirin for chronic hepatitis C. Cessation of…”
Get more information
Journal Article -
15
Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma
Published in Journal of digestive diseases (01-09-2015)“…Objectives Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC) with distant metastasis, unresectable HCC, and those refractory to…”
Get full text
Journal Article -
16
Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib
Published in Oncology (01-01-2017)“…To evaluate the impact of hepatitis C virus (HCV) eradication on the clinical outcome of patients with HCV-related advanced hepatocellular carcinoma (HCC)…”
Get more information
Journal Article -
17
Efficacy of radiofrequency ablation for initial recurrent hepatocellular carcinoma after curative treatment: Comparison with primary cases
Published in European journal of radiology (01-08-2015)“…Highlights • We compared clinical and outcome factors after RFA treatment between primary HCC and recurrent HCC. • Local tumor control and OS are similar, but…”
Get full text
Journal Article -
18
-
19